Adam Kovalčík showed off a poster about his research at the Regeneron International Science and Engineering Fair in Columbus, Ohio.Chris Ayers Photography/Licensed by Society for Science When Adam ...

WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to participate in its PreCheck pilot program, designed to boost domestic drug supply by speeding ...

A single type of chemical structure that shows up again and again in modern medicine is the amide bond that links a carbonyl group (C=O) to a nitrogen atom. They're so ubiquitous that 117 of the top ...

The U.S. Food and Drug Administration has awarded the National Institute for Pharmaceutical Technology and Education a grant worth up to $35 million over the next five years to improve drug ...

Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments. Many of those projects have centered on later stages of the production ...

President Donald Trump on Monday signed an executive order to incentivize prescription drug manufacturing in the U.S., streamlining the path for pharmaceutical companies to build new production sites ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

On May 5, President Trump signed an executive order aimed at boosting domestic production of prescription drugs and active ingredients. Six details: 1. In the U.S., bringing new drug manufacturing ...

Narcotic supply chain disruptions could spark the spread of illicit labs across the U.S. Law enforcement agencies should recognize the risk, emphasize training, and put a ...

A new analysis found that nearly 700 drugs approved for use in the United States depend on chemicals solely produced in China. By Rebecca Robbins For years, Democrats and Republicans have sounded the ...

Adam Kovalčík, age 19, innovated a cheaper, faster way to produce an antiviral drug. Galidesivir targets RNA viruses like COVID-19, Ebola, and Zika but hasn't completed clinical trials. Kovalčík won a ...